{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:25:25Z","timestamp":1789244725724,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019417","name":"Pittsburgh Liver Research Center, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA258449"],"award-info":[{"award-number":["R01CA258449"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30DK120531"],"award-info":[{"award-number":["P30DK120531"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jcmgh.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T01:55:02Z","timestamp":1709171702000},"page":"885-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trailblazing TRAIL Therapy: Illuminating Pathways for Cholangiocarcinoma Treatment"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6079-5939","authenticated-orcid":false,"given":"Sungjin","family":"Ko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2024.02.008_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"Brindley","year":"2021","journal-title":"Cholangiocarcinoma. Nat Rev Dis Primers"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2023.05.010","article-title":"Immunobiology of cholangiocarcinoma","volume":"79","author":"Tomlinson","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib4","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","article-title":"Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL\u00a0resistance via\u00a0an Akt-signaling pathway in cholangiocarcinoma cells","volume":"128","author":"Kobayashi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jcmgh.2024.01.006","article-title":"Noncanonical TRAIL signaling promotes myeloid-derived suppressor cell abundance and tumor growth in cholangiocarcinoma","volume":"17","author":"Loeuillard","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib6","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.7314\/APJCP.2015.16.16.6991","article-title":"TRAIL in combination with subtoxic 5-FU effectively inhibit cell proliferation and induce apoptosis in cholangiocarcinoma cells","volume":"16","author":"Sriraksa","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.23729","article-title":"A\u00a0smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells","volume":"52","author":"Fingas","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.02.008_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12032-023-02129-z","article-title":"6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5","volume":"40","author":"Wang","year":"2023","journal-title":"Med Oncol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:35:20Z","timestamp":1762454120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X24000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2352345X24000365"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.02.008","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trailblazing TRAIL Therapy: Illuminating Pathways for Cholangiocarcinoma Treatment","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.01.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}